A lightweight assessment method for medical device

software processes by McCaffery, Fergal et al.
 A. Mitasiunas et al. (Eds.): SPICE 2014, CCIS 477, pp. 144–156, 2014. 
© Springer International Publishing Switzerland 2014 
A Lightweight Assessment Method for Medical Device 
Software Processes 
Fergal McCaffery, Paul Clarke, and Marion Lepmets 
Regulated Software Research Centre, Dundalk Institute of Technology, Dundalk, Ireland 
{Fergal.Mccaffery,Paul.Clarke,Marion.Lepmets}@dkit.ie 
Abstract. This paper outlines the MDevSPICE-Adept process assessment 
method. MDevSPICE-Adept is a lightweight process assessment method that 
has been created for the MDevSPICE software process assessment model which 
is currently being developed for the medical device industry. MDevSPICE is a 
fully validated release of a medical device software process assessment model 
(formerly known as Medi SPICE), which was developed by the authors. While 
the MDevSPICE process assessment model is detailed and comprehensive, 
there is industry demand for a lightweight medical device software process 
assessment method. To address this requirement the MDevSPICE-Adept 
method has been developed. Details on how this has taken place and the 
procedures for implementing an MDevSPICE-Adept process assessment are 
presented. Information is also provided regarding how an MDevSPICE process 
assessment was undertaken in an Irish based medical device company. A 
summary of the issues identified from this process assessment and the actions 
taken to facilitate process improvement is also presented. Finally, plans for 
future work are discussed.  
Keywords: Medical Device Software, Software Process Improvement, 
Lightweight Process Assessment Method, Medical Device Software Process 
Assessment, MDevSPICE. 
1 Introduction 
Due to the potential threat that medical devices pose to patients, clinicians and third 
parties their development is highly regulated. In recent years there has been a 
significant increase in the role and importance that software plays in the healthcare 
industry [1]. The outcome of this has been the substantial increase in the functionality, 
complexity and size of software components in medical devices [2]. This 
development has been recognized by the European Union (EU) in their latest 
amendment to the Medical Devices Directive (MDD) (2007/47/EC) [3]. As a result, 
standalone software may now be classified as an active medical device in its own 
right in the EU. Given the importance and relevance of this measure, the European 
Commission released a guidance document for the qualification and classification of 
standalone medical device software MEDDEV 2.1/6 [4] in January 2012. In the 
United States (US), the Food and Drug Administration (FDA) are responsible for the 
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regulation and approval of medical devices and have published software specific 
guidance documents for medical device software developers, such as the General 
Principles of Software Validation [5], Off-the-Shelf Software Use in Medical Devices 
[6] and Guidance on the Content of Premarket Submissions for Software Contained in 
Medical Devices [7]. To address the increasingly important role that software now 
plays, the FDA recently published the Medical Device Data Systems Final Rule [8] 
and Draft Guidance in Relation to Mobile Applications [9]. 
Given the mission critical nature of medical device software compliance with the 
relevant regulations, international standards and guidance documents of the region 
where a medical device is to be marketed is obligatory [10]. In the EU, the receipt of 
the CE mark is essential and in the US, FDA approval is required. There are approval 
bodies performing similar roles in other countries including China, Canada, India, 
Japan, and Australia. A key international standard for achieving regulatory 
compliance is IEC 62304:2006 [11] and its aligned standards ISO13485:2003 [12], 
ISO 14971:2007 [13], EN 60601-1:2005 [14], IEC 62366:2007 [15] and IEC 
60812:2006 [16]. Information is also provided in relevant technical reports  IEC/TR 
80002-1:2009 [17] and IEC/TR 61508:2003 [18]. Despite the provision of these 
international standards, technical reports, regulations and guidance documents, the 
information they offer is high-level and no specific methods for performing the 
essential activities required have been provided [19]. 
It is therefore not surprising, given the importance that achieving regulatory 
approval plays, that organizations developing medical device software have focused 
on achieving compliance rather than implementing efficient processes and 
undertaking process improvement [20]. Previously this was not a critical issue due to 
the limited proportion of software in medical devices and it was acceptable to take a 
compliance centric approach. This is no longer the case and there is now a particular 
requirement for highly effective and efficient software development processes to be in 
place. These processes need to be defined in a regulatory compliant manner and then 
adopted to produce the required deliverables in order to achieve approval [19]. To 
address this requirement, MDevSPICE (formerly known as Medi SPICE [21]), a 
medical device software process assessment model (PAM) is being developed and 
validated, which will be made available to the international medical device industry 
during November 2014. While the MDevSPICE PAM is a comprehensive and 
detailed process assessment model based on process reference model (PRM) both of 
which are described in Section 2, there is also industry demand for a lightweight 
medical device software process assessment method [22]. The MDevSPICE-Adept 
process assessment method has been developed to help address this requirement and 
this is discussed in section 3 along with the procedure for its implementation. Section 
4 outlines how a MDevSPICE-Adept process assessment was undertaken and 
provides a summary of the process improvement plan which was collaboratively 
developed based on the findings report. Section 5 provides a summary and context for 
future work based on this research. 
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2 PRM and PAM of MDevSPICE 
Existing software process models like the Capability Maturity Model Integration 
(CMMI) [23] and ISO 15504-5:2012 [24] (SPICE) describe generic software 
development best practices and were not developed to provide coverage of all the 
necessary areas required to achieve domain specific requirements such as medical 
device regulatory compliance [25]. To address the requirement for a medical device 
software development, the Regulated Software Research Centre (RSRC) at Dundalk 
Institute of Technology (DkIT) undertook extensive research in the area [19]. This 
resulted in work commencing on the development of MDevSPICE PAM (initially 
known as Medi SPICE), a medical device specific process assessment model, which 
is being developed in collaboration with the SPICE community, the international 
medical device standards community and the international medical device software 
industry. This process assessment model is in line with Automotive SPICE [26], a 
domain specific process assessment model for the automotive industry.  
The MDevSPICE PAM is based upon the latest version of ISO/IEC 15504-5:2012 
and provides coverage of the relevant medical device regulations, standards, technical 
reports and guidance documents, as illustrated on Fig.1. These include IEC 
62304:2006 and its aligned standards (ISO 14971 [13], ISO 13485 [12], IEC TR 
80002-1 [17], IEC 62366 [15], IEC 60601-1 [14], IEC 82304 [27]), the FDA guidance 
documents on premarket submission [7], off-the-shelf software use [6] and software 
validation [5]. The MDevSPICE PAM is partly founded upon the process reference 
model for IEC 62304 (IEC TR 80002-3:2014 [28]) as this is the standard for medical 
device software life cycle processes and is therefore the pivotal standard for medical 
device software development. It is also worth noting that the development of IEC TR 
80002-3 was initiated and lead by the authors (since October 2010) in association with 
the International medical device standards community combining the requirements 
from IEC 62304:2006 and ISO/IEC 12207:2008 [29]. Both IEC 62304 and IEC TR 
80002-3 describe the process requirements for different software safety classes. This 
feature has also been carried forward to the MDevSPICE PAM where each process 
outcome derived from IEC 62304 indicates the safety class for which it is required.  
software product safety requirements 
and practices:
IEC 82304
risk management requirements and 
practices:
ISO 14971
IEC 80002-1
medical device software development 
requirements and practices:
IEC 62304
IEC TR 80002-3
FDA guidance documents
generic software development 
requirements and practices:
ISO/IEC 12207
ISO/IEC 15504
electrical and usability engineering 
practices:
IEC 62366
IEC 60601-1
quality management system 
requirements and practices:
ISO 13485
MDevSPICE® PAM
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Fig. 1. Collection of requirements and practices of MDevSPICE PAM 
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The MDevSPICE PAM contains a Process Reference Model (PRM) which extends 
the requirements from IEC TR 80002-3 to include requirements from system level 
and supporting processes described in ISO/IEC 12207:2008. The MDevSPICE PRM 
consists of 24 processes which are fundamental to the development and maintenance 
of regulatory compliant medical device software. Each process has a clearly defined 
purpose and process outcomes that must be accomplished to achieve that purpose. 
One way to achieve these process outcomes is through implementing the base 
practices described in the MDevSPICE PAM. The MDevSPICE PAM extends the 
PRM with additional process elements of base practices and work products and the 
measurement framework allowing process capability ratings. Similarily to ISO/IEC 
15504-5, the MDevSPICE PAM also has two-dimensional view of process capability. 
In one dimension, it describes a set of base practices that allow the achievement of the 
process outcomes and purpose defined in the PRM; this is termed the process 
dimension.  In the other dimension, the PAM describes capabilities that relate to the 
process capability levels and process attributes, this is termed the capability 
dimension. 
The MDevSPICE PAM extends the PRM with a set of work products for every 
process that are the inputs and outputs of the processes. In ISO/IEC 15504-5, work 
products are the informal evidence collected to support the process capability rating. 
In MDevSPICE PAM, these are both informal as well as normative, i.e. mandatory 
work products as required in the regulatory standards. The existence of these 
mandatory work products together with their required content are addressed as 
process outcomes during the process assessment. 
The MDevSPICE PAM also includes the measurement framework, which is based 
on ISO/IEC 15504-2:2003 [30]. Similarly to ISO/IEC 15504-2, the MDevSPICE 
PAM also has six process Capability Levels, with one or more process attributes per 
Capability Level from Level 1 onwards. 
The objective of undertaking an MDevSPICE process assessment is to determine 
the state of a medical device organisation’s software processes and practices in 
relation to the regulatory requirements of the industry and to identify areas for process 
improvement [31]. It can also be used as part of the  supplier selection process when 
an organisation wishes to outsource or offshore part or all of their medical device 
software development to a third party or remote division [32]. An MDevSPICE 
process assessment can also be conducted for pre-qualification purposes as it provides 
a preliminary readiness overview of regulatory compliance. 
The MDevSPICE PRM and PAM were released in stages and each stage was 
extensively reviewed by interested parties from the SPICE community, 
representatives from international standards bodies and medical device industry 
experts. This collaborative approach is seen as a key element in the development of 
the MDevSPICE PAM to ensure coverage of both the generic software best practices 
and medical device software regulatory requirements [31]. The MDevSPICE PAM is 
a comprehensive and detailed process assessment model and its overall objective is to 
provide both process capability and conformity assessment ratings to support first, 
second or third party assessments. It is envisaged that results from these assessments 
may be recognized by the relevant regulatory bodies. 
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3 Requirements for MDevSPICE-Adept Process Assessment 
Method 
As outlined in section two, there is a specific requirement for a detailed and 
comprehensive process assessment model, which is specific to the medical device 
domain and that MDevSPICE PAM is addressing. as with other process models i.e. 
CMMI and IEC 15504-5:2012. A full MDevSPICE process assessment will require 
considerable planning and resources to successfully undertake. While MDevSPICE 
process assessment is being developed with the objective of being as efficient as 
possible, the necessity for rigour dictates the level of planning, resources and analysis 
required for its successful implementation. While the need for and importance of 
MDevSPICE process assessment is understood [21], it was also appreciated by the 
RSRC that there is a specific requirement for a lightweight assessment method in the 
medical device software industry [33]. In particular, there was industry led demand 
for a lightweight assessment method based on the MDevSPICE PAM. This was 
communicated directly to the RSRC by numerous medical device organisations. To 
address this specific requirement, the MDevSPICE-Adept method was developed. 
This also provided an opportunity to leverage the extensive research [19] and level of 
detail, which developing the MDevSPICE PAM required. 
A process assessment method provides a process description for conducting 
process assessments. The rigour of the method depends on the purpose of the process 
assessment. For Class 3 third-party assessment, the rigour is highest i.e. the amount of 
evidence collected and analysed is greatest, and assessor competence and experience 
highest. The more rigorous the chosen process assessment method, the more detailed 
are the process assessment results. On the other hand, the more rigorous the method, 
the more resource-demanding and time-consuming is the process assessment. 
To be effective, MDevSPICE-Adept required the employment of a lightweight 
approach for undertaking software process assessment and improvement. This 
included the use of a limited number of personnel to carry out and participate in the 
assessment while also maximising the benefit of the time and effort of those involved. 
It was envisaged that MDevSPICE process assessment would eventually encompass 
all the MDevSPICE PAM processes. It was therefore recognized that an assessment 
could take place over a day or a number of days depending on how many processes 
were being assessed. It was also important that organizations could select the specific 
processes which were of most benefit for achieving their business goals. The focus of 
the method had to be on the evaluation of the essential base practices, key work 
products and the achievement of the process outcomes which were necessary for the 
attainment of the specific process purpose being assessed. MDevSPICE-Adept 
therefore needed to be process dimension centric in its focus. Finally, the objective of 
undertaking an MDevSPICE-Adept process assessment was not to receive formal 
certification, but rather to identify an organization’s strengths and weaknesses and to 
facilitate process improvement. Having defined the criteria which had to be met, the 
next step was to undertake the development of MDevSPICE-Adept method. 
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3.1 Developing the MDevSPICE-Adept Method 
The RSRC, having previously successfully developed and implemented three 
lightweight software process assessment methods Adept [33], Med-Adept [34] and 
Med-Trace [35], the objective was to leverage that experience and utilise it for the 
development of MDevSPICE-Adept. It was in this context that work commenced on 
the development of MDevSPICE-Adept. It was recognized that this process 
assessment method needed to cover more processes and provide more detailed 
analysis than those methods which had been previously developed. While this was the 
case, MDevSPICE-Adept was still required to be lightweight to satisfy the industry 
demand. The MDevSPICE-Adept method was developed through process assessment 
engagements in medical device industry. 
The first task was to identify the initial set of processes that would be included in 
the MDevSPICE process assessment. The goal was to select a limited number of 
processes that would be most beneficial and relevant to industry with the onsite 
process assessment no longer than 2 days. To achieve this, industry experts were 
consulted on the 24 processes of the PAM from which they selected the preliminary 
11 processes (most of which are from IEC 62304): 
• System requirements analysis 
• Software development planning 
• Software requirements analysis 
• Software architectural design 
• Software detailed design 
• Software unit implementation and verification 
• Software integration and integration testing 
• Software system testing 
• Software risk management 
• Software configuration management 
• Software problem resolution 
While these were the initial processes selected for inclusion in MDevSPICE-
Adept, it is also possible to extend this list of processes to provide coverage of all the 
MDevSPICE processes. This can only be done with an extended onsite process 
assessment demanding more time and resources from the company that is being 
assessed. 
The MDevSPICE PAM had been developed for each of the initial processes which 
were based on best practice as outlined by the latest version of ISO/IEC 15504-5 and 
the specific requirements of the medical device regulations, standards, technical 
reports and guidance documents. As a result, each process had a defined purpose and 
process outcomes, base practices and work products were also included for the 
achievement of these process outcomes and process purpose. In addition, each 
outcome and base practice was cross referenced to the standard they were derived 
from. To facilitate the process assessment, each of the initial processes were evaluated 
and specific questions identified based on the MDevSPICE PAM. This work was 
undertaken by six members of the RSRC team with extensive experience in SPI and 
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knowledge of medical device software development. Having defined the assessment 
instrument, the next step was to develop the specific process for undertaking an 
MDevSPICE assessment. 
The objective of MDevSPICE-Adept is to assist an organisation to gain an 
understanding of the state of their current software development processes when 
measured against the selected MDevSPICE PAM processes. The MDevSPICE PAM 
is essentially a “one stop shop” for all associated medical device software related 
requirements. The MDevSPICE PAM contains the requirements of all the software 
related medical device standards and the additional software engineering best 
practices from ISO/IEC 15504-5. Even though the MDevSPICE process assessment 
does not provide any official certification against any of the medical device standards, 
the output of the assessment will provide both the MDevSPICE process capability 
rating as well as the gaps that exist against the requirements of the medical device 
software standards included in the MDevSPICE PAM. This type of combinatory 
process assessment result allows targeted activities for both process improvement and 
an increased regulatory compliance to be undertaken by the assessed organization. 
3.2 The Procedure for Undertaking a Lightweight MDevSPICE Process 
Assessment Following the MDevSPICE-Adept Method 
Based on the RSRC’s previous experience of developing and undertaking lightweight 
software process assessments [33], the seven stage procedure for undertaking an 
MDevSPICE Assessment following the MDevSPICE-Adept method was defined. It 
was decided the assessment team should normally consist of two assessors who share 
responsibility for conducting the assessment. 
The seven stages of the procedure are as follows: As a precursor to undertaking an 
assessment a preliminary meeting between the lead assessor and the company takes 
place. This is the first stage in the procedure and during this meeting the lead 
assessors discusses the main drivers for the company wishing to undertake an 
assessment. In this context the expectations regarding what can be realistically 
achieved are discussed and the procedure for undertaking the assessment is outlined.  
If there is agreement a schedule is drawn up. 
At the second stage the lead assessor has a meeting with the staff and management 
from the company who will be participating in the assessment where an overview of 
the MDevSPICE-Adept assessment method is presented and details of what their 
participation will involve is outlined.  
On the agreed date the onsite assessment commences which is the third stage in the 
procedure. For each process the lead assessor conducts interviews based on the 
scripted MDevSPICE-Adept questions with the relevant personnel and evaluates the 
responses. The second assessor who also participates in the interviews prepares 
interview notes and may ask additional questions when clarification is required. In 
addition work products may also be requested and reviewed as part of this stage.   A 
maximum of five processes are assessed in a single day with the interviews for each 
process taking approximately one hour. 
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At the fourth stage the findings report is prepared off site based on the data 
gathered at stage three. Each process is reviewed in turn and relevant strengths and 
issues (weaknesses) are identified based on the evaluation and interview notes. 
Suggested actions to address these issues and to facilitate process improvement are 
outlined and discussed. The possibility for the use of appropriate agile and lean 
practices is also considered. These are then documented and included in the findings 
report. This is a joint effort between the assessors and may include other SPI and/or 
lean and agile experts if required. 
The findings report is then presented to the management and staff who took part in 
the assessment which is the fifth stage in the procedure. 
Having provided adequate time for the findings report to be read and considered by 
the organization, at the sixth stage the contents of the report is discussed in detail with 
the relevant management and staff. At this point specific objectives for process 
improvement are collaboratively defined based on the findings report which results in 
the development of a process improvement plan. Given the lightweight nature of 
MDevSPICE-Adept improvements that offer the greatest benefits in terms of 
compliance, quality and the achievement of business goals are selected for inclusion 
in this plan. 
At the seventh stage in the procedure the organization having implemented the 
process improvement plan have the opportunity of having the processes reassessed. 
Based on this, a final detailed report is prepared which highlights what has been 
achieved and an updated improvement plan is also provided. 
4 Conducting the Lightweight MDevSPICE Process Assessment 
Following the MDevSPICE-Adept Method 
Having developed the MDevSPICE-Adept Assessment method and the procedure for 
its implementation the first assessment took place in an Irish based medical device 
company Irish Medical (a pseudonym).  The company develops both automotive and 
medical device software. Each of their products contains both hardware and software 
and the role that software plays has considerably increase over the last number of 
years. They produce software for medical devices that will be marketed in the EU and 
the US so their products must conform to the MDD to receive the CE mark and the 
FDA regulations. 
Having agreed that an assessment would take place (Stage 1), it was decided by the 
company that 10 out of the 11 processes would be assessed over a two day period 
(Stage 2). Software problem resolution process was omitted as an explicit process for 
managing problems did not exist in the Irish Medical at the time of the process 
assessment. The process assessment, i.e. Stage 3, was undertaken by two assessors 
from the RSRC. Based on the results of the process assessment, a findings report was 
prepared and presented in Stage 4. The focus of the report was that for each process 
the strengths and issues were highlighted, in addition suggested actions to facilitate 
process improvement were provided. Based on the findings report, the process 
improvement objectives and process improvement plan were collaboratively defined 
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and developed with the company (Stage 5-6). A summary of the issues identified for 
each process and the actions taken to address these issues and facilitate improvement 
were outlined in the process improvement plan of Stage 7. 
Irish Medical decided that the 10 critical processes to be assessed are the 
following: 
• System requirements analysis 
• Software development planning 
• Software requirements analysis 
• Software architectural design 
• Software detailed design 
• Software unit implementation and verification 
• Software integration and integration testing 
• Software system testing 
• Software risk management 
• Software configuration management 
All of the 10 processes are described in IEC 62304 and IEC TR 80002-3 with the 
exception of System requirements analysis. This is an important process for Irish 
Medical as it develops software for embedded medical device systems and requires 
efficient traceability of requirements from system level to software level. 
In conducting the process assessment in Irish Medical, it was possible to not just 
highlight strengths and weaknesses in the process implementation, but it was also 
possible to tailor the scope of the process assessment to suit the needs of the 
organisation. Fig 2 below demonstrates the coverage of the process assessment from 
the underlying standards perspective. In practice, additional standards can be added to 
full MDevSPICE assessments but for the purpose of this MDevSPICE-Adept process 
assessment, this coverage was deemed sufficient. 
 
 
Fig. 1. Scope of Irish Medical process assessment from the underlying standards perspective  
One of the primary observations from this process assessment was the extent to 
which the basic requirements of IEC 62304 were in fact supplemented with best 
practice know-how from a range of other standards, thus resulting in a more thorough 
evaluation of the software development process capability. It is furthermore the case 
that for each of the underlying sources, it is possible to also produce findings in 
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relation to coverage of that particular standard – and not just for individual processes 
but for groups of processes and the process set as a whole. For example, Figure 3 
demonstrates how an overall coverage of software development process requirements 
for safety class C software development based on IEC 62304 might appear. 
At an individual process level, the participating company was provided with 
detailed information on the process capability rating and areas of greatest weakness. 
One example of such related to software configuration management, an area that the 
organisation is now actively addressing.  
The findings report was positively received by Irish Medical as was the whole 
process assessment. The collaborative nature of the development of the process 
improvement plan provides motivation for it successful implementation. The plan is 
currently being implemented and when this is complete the opportunity to have the 
processes reassessed is available – and the company in question is positively 
predisposed to introducing a regular process assessment in order to better understand 
and improve their software processes. The process assessment also identified areas of 
strength in the organisation. For example, the company had very good risk 
management and traceability procedures in place. It is important to state that the 
MDevSPICE-Adept process assessment method highlights the strengths as well as the 
weaknesses in an organization. 
 
 
Fig. 2. Sample IEC 62304 safety class C coverage 
5 Conclusion 
The MDevSPICE framework consists of both the MDevSPICE PAM and the 
MDevSPICE-Adept process assessment method. The MDevSPICE PAM is a 
comprehensive and detailed domain specific process assessment model for medical 
device software development. It provides the basis for in-depth analysis and 
assessment of each process including the measurement framework for process 
capability determination. As a result, the findings from a Class 3 MDevSPICE 
process assessment can be comprehensive and detailed. On the other hand, 
MDevSPICE-Adept as a Class 1 lightweight assessment method has a different 
purpose. Its focus is high level and its role is to provide a snap shot of medical device 
software development processes, and to assist with regulatory compliance and process 
improvement in this context.  
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MDevSPICE-Adept is the largest and most detailed of the lightweight assessment 
methods developed by the RSRC. It is the result of industry demand and was 
developed to meet the requirement for an extensive yet lightweight medical device 
software assessment method. A pilot MDevSPICE-Adept assessment has recently 
been successfully implemented in Ireland. Feedback from the assessment was very 
positive. In line with our strategy for MDevSPICE-Adept method, we will develop 
various sets of initial processes based on the different demands of medical device 
software development organizations based on compliance requirements with specific 
standards. Given the level of demand it is also our objective to carry out additional 
MDevSPICE-Adept assessments both in Ireland and in collaboration with our 
international colleagues. We also plan to release Class 1 and Class 2 MDevSPICE 
process assessment methods in November 2014. 
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